Xue-Quan Fang Selected Research

Anticholesteremic Agents

1/2021

Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue-Quan Fang Research Topics

Disease

3	Neoplasms (Cancer) 04/2022 - 09/2020
3	Lung Neoplasms (Lung Cancer) 04/2022 - 09/2020
2	Atrophy 04/2022 - 02/2009
2	Melanoma (Melanoma, Malignant) 01/2021 - 09/2020
1	Cachexia 04/2022
1	Malignant Mesothelioma 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Facial Paralysis (Facial Palsy) 02/2009

Drug/Important Bio-Agent (IBA)

1	Parathyroid Hormone (Parathormone)IBA 04/2022
1	Emodin (Archin)IBA 04/2022
1	Therapeutic UsesIBA 04/2022
1	Parathyroid Hormone-Related ProteinIBA 04/2022
1	Hormones (Hormone)IBA 04/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Fluvastatin FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Anticholesteremic AgentsIBA 01/2021
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2021
1	Mevalonic Acid (Mevalonate)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Cyclin D1IBA 09/2020
1	Pharmaceutical PreparationsIBA 09/2020
1	CateninsIBA 09/2020
1	cinobufaginIBA 09/2020

Therapy/Procedure

1	Therapeutics 01/2021
1	Transplantation 02/2009